In Thursday’s Wall Street session, Dexcom Inc (NASDAQ:DXCM) shares traded at $82.85, down -0.17% from the previous session.
DXCM stock price is now 6.93% away from the 50-day moving average and 8.20% away from the 200-day moving average. The market capitalization of the company currently stands at $32.49B.
With the price target of $104, Goldman recently initiated with Buy rating for Dexcom Inc (NASDAQ: DXCM). On April 10, 2025, Mizuho recently initiated its ‘Outperform’ rating on the stock quoting a target price of $85, while ‘Redburn Atlantic’ rates the stock as ‘Buy’
In other news, AUGUSTINOS NICHOLAS, Director bought 6,290 shares of the company’s stock on Jun 09 ’25. The stock was bought for $546,664 at an average price of $86.91. An SEC document containing details of the transaction can be found on the SEC’s website. On May 27 ’25, EVP, Chief HR Officer Stern Sadie sold 6,184 shares of the business’s stock. A total of $526,318 was realized by selling the stock at an average price of $85.11. This leaves the insider owning 109,621 shares of the company worth $9.08 million. A total of 1.44% of the company’s stock is owned by insiders.
During the past 12 months, Dexcom Inc has had a low of $57.52 and a high of $118.80. As of last week, the company has a debt-to-equity ratio of 1.14, a current ratio of 1.50, and a quick ratio of 1.32.
The net profit margin was 12.90% and return on equity was 23.72% for DXCM.
